Home > News > Centre to partly fund the cost of advanced R&D by biotech firms
December 31st, 2007
Centre to partly fund the cost of advanced R&D by biotech firms
Abstract:
The SCPP idea has been approved in principle, but would be placed before the government for formalization within a month. Meanwhile, DBT has sought industry proposals until March. Unlike the Small Business Innovation Research Initiative, or Sbiri, which is meant for small-and medium enterprises, SCPP is open to companies of all sizes.
"This would enable the industry to invest in areas like RNA interference, or RNAi, (a naturally occurring process that suppresses certain gene activity in cells and has evolved into a therapeutic technique to modulate the activity of single genes), nanotechnology-based fluidics, stem cells, et al., where the industry is currently not investing," said S. Natesh, a senior adviser at DBT in New Delhi. It would also include technologies for orphan crops, such as drought-resistant wheat and rice, those that can deal with environmental calamities, drugs and vaccines for national emergencies, and in such areas where initial commercialization looks unattractive for the industry.
Source:
livemint.com
Bookmark:
| Related News Press |
News and information
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Govt.-Legislation/Regulation/Funding/Policy
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025
Chainmail-like material could be the future of armor: First 2D mechanically interlocked polymer exhibits exceptional flexibility and strength January 17th, 2025
Announcements
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||